In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure
High dose bee venom exposure in beekeepers by natural bee stings represents a model to understand mechanisms of T cell tolerance to allergens in healthy individuals. Continuous exposure of nonallergic beekeepers to high doses of bee venom antigens induces diminished T cell–related cutaneous late-pha...
Saved in:
Published in | The Journal of experimental medicine Vol. 205; no. 12; pp. 2887 - 2898 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Rockefeller University Press
24.11.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | High dose bee venom exposure in beekeepers by natural bee stings represents a model to understand mechanisms of T cell tolerance to allergens in healthy individuals. Continuous exposure of nonallergic beekeepers to high doses of bee venom antigens induces diminished T cell–related cutaneous late-phase swelling to bee stings in parallel with suppressed allergen-specific T cell proliferation and T helper type 1 (Th1) and Th2 cytokine secretion. After multiple bee stings, venom antigen–specific Th1 and Th2 cells show a switch toward interleukin (IL) 10–secreting type 1 T regulatory (Tr1) cells. T cell regulation continues as long as antigen exposure persists and returns to initial levels within 2 to 3 mo after bee stings. Histamine receptor 2 up-regulated on specific Th2 cells displays a dual effect by directly suppressing allergen-stimulated T cells and increasing IL-10 production. In addition, cytotoxic T lymphocyte–associated antigen 4 and programmed death 1 play roles in allergen-specific T cell suppression. In contrast to its role in mucosal allergen tolerance, transforming growth factor β does not seem to be an essential player in skin-related allergen tolerance. Thus, rapid switch and expansion of IL-10–producing Tr1 cells and the use of multiple suppressive factors represent essential mechanisms in immune tolerance to a high dose of allergens in nonallergic individuals. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 F. Meiler and J. Zumkehr contributed equally to this paper. Abbreviations used: CTLA, CTL-associated antigen; HR, histamine receptor; PD, programmed death; PLA, phospholipase A2; PPD, purified protein derivative; SIT, specific immunotherapy; TCRVβ, TCR variable β; Tr1, type 1 T regulatory; TT, tetanus toxoid. CORRESPONDENCE Mübeccel Akdis: akdism@siaf.unizh.ch |
ISSN: | 0022-1007 1540-9538 1540-9538 |
DOI: | 10.1084/jem.20080193 |